These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9859820)

  • 1. P53 overexpression and DNA aneuploidy in colorectal adenocarcinomas.
    Monaco R; Capasso A; Bellomo PF; Geido E; Giaretti W
    Eur J Histochem; 1997; 41 Suppl 2():139-40. PubMed ID: 9859820
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
    Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
    Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
    Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
    Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma.
    Biesterfeld S; Schreiber H
    Virchows Arch; 1995; 427(4):459. PubMed ID: 8548134
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics of colorectal cancers].
    Pocard M; Salmon RJ
    Ann Chir; 1996; 50(3):211-6. PubMed ID: 8763122
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
    Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
    Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
    Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
    J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
    Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
    Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability.
    Wynter CV; Simms LA; Buttenshaw RL; Biden KG; Young J; Leggett BA; Conrad RJ; Schoch EM; Jass JR; Praga Pillay S
    J Pathol; 1999 Nov; 189(3):319-25. PubMed ID: 10547592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
    Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
    Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.